Commit To Buy Regulus Therapeutics At $10, Earn 21.5% Annualized Using Options
May 26, 2015 at 11:37 AM EDT
Investors eyeing a purchase of Regulus Therapeutics Inc (RGLS) stock, but cautious about paying the going market price of $12.67/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $10 strike, which has a bid at the time of this writing of $1.05..